- Open Access
Characterization of a panel of six β2-adrenergic receptor antibodies by indirect immunofluorescence microscopy
© Koryakina et al. 2008
- Received: 02 November 2007
- Accepted: 18 April 2008
- Published: 18 April 2008
The β2-adrenergic receptor (β2AR) is a primary target for medications used to treat asthma. Due to the low abundance of β2AR, very few studies have reported its localization in tissues. However, the intracellular location of β2AR in lung tissue, especially in airway smooth muscle cells, is very likely to have a significant impact on how the airways respond to β-agonist medications. Thus, a method for visualizing β2AR in tissues would be of utility. The purpose of this study was to develop an immunofluorescent labeling technique for localizing native and recombinant β2AR in primary cell cultures.
A panel of six different antibodies were evaluated in indirect immunofluorescence assays for their ability to recognize human and rat β2AR expressed in HEK 293 cells. Antibodies capable of recognizing rat β2AR were identified and used to localize native β2AR in primary cultures of rat airway smooth muscle and epithelial cells. β2AR expression was confirmed by performing ligand binding assays using the β-adrenergic antagonist [3H] dihydroalprenolol ([3H]DHA).
Among the six antibodies tested, we identified three of interest. An antibody developed against the C-terminal 15 amino acids of the human β2AR (Ab-Bethyl) specifically recognized human but not rat β2AR. An antibody developed against the C-terminal domain of the mouse β2AR (Ab-sc570) specifically recognized rat but not human β2AR. An antibody developed against 78 amino acids of the C-terminus of the human β2AR (Ab-13989) was capable of recognizing both rat and human β2ARs. In HEK 293 cells, the receptors were predominantly localized to the cell surface. By contrast, about half of the native rat β2AR that we visualized in primary cultures of rat airway epithelial and smooth muscle cells using Ab-sc570 and Ab-13989 was found inside cells rather than on their surface.
Antibodies have been identified that recognize human β2AR, rat β2AR or both rat and human β2AR. Interestingly, the pattern of expression in transfected cells expressing millions of receptors was dramatically different from that in primary cell cultures expressing only a few thousand native receptors. We anticipate that these antibodies will provide a valuable tool for evaluating the expression and trafficking of β2AR in tissues.
- Airway Smooth Muscle
- Airway Smooth Muscle Cell
- Indirect Immunofluorescence Microscopy
- Penultimate Amino Acid
- Constitutive Internalization
The β2-adrenergic receptor (β2AR) is found in several cell types within the lung where it mediates a number of important functions including relaxation of airway smooth muscle [1–3], activation of ion and fluid transport in epithelial cells , inhibition of mediator release from mast cells , stimulation of surfactant secretion in alveolar type 2 cells and stimulation of mucus secretion by submucosal glands [6–8]. The β2AR in smooth muscle cells is thought to be the principal target for the β-agonist medications used to treat asthma and other obstructive airway diseases. Activation of the β2AR by β-agonists like albuterol or salbutamol is capable of inhibiting (bronchoprotection) or reversing (bronchodilation) contractile processes.
Continuous β-agonist exposure results in tolerance to their bronchodilating effects. The problem of tolerance may pose risks to patients using both short-acting (SABA) and long-acting beta-agonists medications (LABAs). The LABA medications were developed as controller medications. However, in 2005 the U.S. FDA issued a Public Health Advisory stating that the use of LABAs might increase the risk of severe asthma episodes (and death) and advised against the use of LABAs as the first line, monotherapy for the treatment of asthma. It is thought that this clinical tolerance is the result of cellular mechanisms used to attenuate the cellular responses to β-agonist activation of β2AR.
The β2AR is a prototypical G-protein coupled receptor containing seven transmembrane α-helical regions. The N-terminal domain and three loops are located on the extracellular face of the plasma membrane, and the C-terminal domain and three loops are also located on the intracellular (or cytoplasmic) face of the plasma membrane . When activated by ligand binding, β2ARs couple via the third intracellular loop to a heterotrimeric stimulatory Gs-protein resulting in Gsα subunit dissociation, GTP binding, and adenylyl cyclase activation. This occurs within seconds of ligand binding, and the resulting elevation in intracellular cAMP levels is responsible for the relaxation of airway smooth muscle leading to bronchodilation [10, 2].
Bronchodilatory responses are of limited duration because sustained activation of β2AR is accompanied by receptor phosphorylation and by the binding of β-arrestin, thereby inhibiting further interaction and activation of Gs. These events lead to desensitization. β-arrestin also binds coated pit components like AP-2 and clathrin, thereby resulting in endocytosis and a loss in the number of receptors on the cell surface. Thus, both short-term and long-term mechanisms exist for attenuating β2AR signalling .
The recovery in the number of receptors on plasma membrane following endocytosis is largely accomplished by recycling of the intracellular receptors back to the surface. Prolonged or chronic exposure to β-agonists causes trafficking of the receptors to lysosomes and subsequent degradation and loss of the receptors [12, 13]. Much of the intricate regulatory mechanisms involved in β2AR signalling have been defined by using cultured cell lines and recombinant, epitope-tagged receptors expressed at levels much higher than normal. We think that it is important to determine if the mechanisms defined in engineered cell lines are also operational in cells present in a normal physiological setting. Unfortunately, immunological reagents useful for detecting native β2AR in tissues have not been carefully characterized. We have used indirect immunfluorescence microscopy to evaluate a panel of six antibodies for use in visualizing rat and human β2AR in transfected HEK 293 cells and in primary cultures of rat airway epithelial and smooth muscle cells. Our studies indicate that the level of receptor expression may have an impact on the location of receptors within cells.
Cell Culture, Plasmids and Transfection
The human embryonic cell line, HEK 293, was maintained in Dulbecco's modified Eagle's medium/Ham's F12 (50:50) (Cellgro, Herndon, VA) supplemented with 5% calf serum, 1% antibiotic/antimycotic in a 5% CO2 incubator at 37°C. HEK 293 cells stably expressing human β2AR  were maintained in media containing 200 μg/ml G418 (Cellgro). The expression plasmid pExpress1-ratβ2-AR was purchased from ATCC. Cells were transiently transfected with pExpress1-ratβ2-AR (1 μg/35 mm dish) using the calcium phosphate precipitation method [15, 16]. A cDNA encoding human β2AR was fused to the N-terminus of pEYFP-N1 (Clontech, Mountain View, CA) [14, 17].
Receptor binding assay on intact cells
Cell monolayers were lifted with cold PBS supplemented with 5 mM EDTA using a rubber policeman and washed twice with PBS by centrifugation. Approximately 1.2 × 106 cells/ml were incubated in triplicate with a single saturating concentration of [3H]Dihydroalprenolol (DHA) (~5 nM) (PerkinElmer, Boston, MA; specific activity = 117.8 Ci/mmol) for 20 minutes at 30°C. Incubations were terminated by vacuum filtration through glass fiber filters presoaked in assay buffer (50 mM Tris, 2 mM MgCl2, pH 7.4) and repeated washes with ice-cold assay buffer. Bound radioactivity was determined by scintillation counting. Nonspecific binding was determined by using 0.1 μM (-)-propranolol (Sigma, St. Louis, MO).
Primary Rat Airway Cell Cultures
The transportation, care, and use of animals for the reported studies was in accordance with the Animal Welfare Act (7 U.S.C. et seq.) and other applicable federal laws, guidelines, and policies. The procedures for handling animals were approved by the Institutional Animal Care and Use Committee of the University of Arkansas for Medical Sciences. Adult female Sprague-Dawley rats (250 g) were euthanized by intraperitoneal injection of Euthasol (0.22 ml/kg). The chest cavity was opened and the trachea and lungs were dissected out and transferred to a dish containing PBS.
Airway smooth muscle cells (ASMC) were generated from explants of excised tracheas. The entire trachea between the larynx and main stem bronchi was removed and placed in a sterile dish containing PBS supplemented with a 2% antibiotic/antimycotic. After additional surrounding tissue was removed with the aid of a dissecting microscope, the tracheal segment was split longitudinally and dissected into 2–3 mm squares. All segments from a single trachea were then placed with the intima side down in separate sterile 35 mm dishes. The explants were incubated in a 5% CO2 incubator at 37°C. After allowing the explants to adhere, 2 ml of DMEM/F12, 20% calf serum, 2% antibiotic-antimycotic was added to cover the explants. Once cells became locally confluent, the serum concentration was reduced to 10%. Media was changed every other day before confluency was achieved (~3 weeks), at which point the tracheal explants were removed.
Rat airway epithelial cell cultures were prepared by intrapulmonary enzyme digestion as follows. Excised lungs were cleared of blood by perfusing PBS (~25 ml) through the pulmonary arteries. The airways were then flushed four times with calcium- and magnesium-free Dulbecco's PBS via the trachea (~40 ml), filled with a microbially produced trypsin-like enzyme (TrypLE, Gibco Invitrogen). The trachea was clamped, and the lung was incubated at 37°C for 75 minutes. Following the intrapulmonary digestion, the airways were washed twice with DMEM/F12, 5% calf serum (~25 ml total) and twice with PBS (~25 ml) to flush out epithelial plaques. The plaques were collected by centrifugation at 900 g for 8 minutes. The pellet was resuspended in DMEM/F12, 5% calf serum and aliquots were cultured on plastic dishes in a 5% CO2 incubator at 37°C for up to one week.
Indirect Immunofluorescence Microscopy
For indirect immunofluorescence microscopy, HEK 293 cells were grown on glass coverslips and treated with or without 10 μM isoproterenol for 4.5 hours. Cells were fixed with freshly prepared 3.6% paraformaldehyde in PBS, blocked and permeabilized in PBS containing 1% BSA, 5% serum and 0.1% Triton X-100. β2AR were visualized using the labeled avidin-biotin method. Samples were incubated with primary antibody followed by separate incubations with biotinylated secondary antibody and with Texas-Red labeled Avidin D (Vector Laboratories Inc., Burlingame, CA). Optimal dilutions of the antibodies were determined in titration experiments. Antibodies were diluted in the permeabilization buffer and samples washed with PBS after each incubation. The nuclei were stained with 30 nM 4,6-diamidinophenylindole (DAPI). Antibody dilutions were as follows: Ab-Bethyl (rabbit polyclonal antipeptide antibody, Bethyl Laboratories Inc., Montgomery, TX), 1:50; Ab-sc570 (rabbit polyclonal antipeptide antibody, Santa Cruz Biotechnology, Santa Cruz, CA), 1:300; Ab-13989 (chicken polyclonal antibody, Abcam, Inc., Cambridge, MA), 1:300. Secondary goat anti-rabbit (Vector Laboratories, Inc.) and rabbit anti-chicken (ab6752, Abcam, Inc.) biotinylated antibodies were used at a dilution of 1:200. Sc569 antibody was from Santa Cruz Biotechnology, IMG-71135 was from Imgenex Corporation, San Diego, CA, and ab13300 was purchased from Abcam.
A similar protocol was used for localization of the endogenous β2AR in primary cultures of rat airway smooth muscle cells (ASMC) and rat airway epithelial cells (AEC) except that the samples were double-labeled with β2AR and cell-type specific marker antibodies. Ab-sc570 and Ab-13989 antibodies were used at a dilution of 1:250. Mouse monoclonal anti-smooth muscle alpha-actin antibody (ab18460, Abcam, Inc.) and mouse monoclonal anti-E-cadherin (BD Transduction Labs, Franklin Lakes, NJ) were used at a dilution of 1:100. Donkey anti-mouse FITC-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) was used at a dilution of 1:250. Ab-sc570 specificity was determined by preincubating the antibody with a five-fold (by weight) excess of blocking peptide (sc570p, Santa Cruz Biotechnology) for 2 hours at room temperature prior to dilution in buffer for indirect immunofluorescence as described above.
All samples were mounted in Fluoromount-G mounting medium (Electron Microscopy Sciences, Hatfield, PA) and visualized by epifluorescence (Axioskop 2 plus microscope, Carl Zeiss Inc., Thornwood, NY) and confocal microscopy (LSM510 Axiovert 200 M confocal microscope, Carl Zeiss Inc.) using a Zeiss Plan-Apo 63× 1.40NA oil immersion objective.
The acquisition settings were kept constant between specimens. Images were stored as a tagged image format.
Data Analysis/Statistical Methods
In radioligand binding experiments, [3H]DHA binding to cells at each time point was measured in triplicate. Each "n" represented data from one set of cell culture plates (one condition). To achieve statistical significance, experiments were performed at n = 4. Data are presented as the mean ± S.E.M. A group t-test was used with p < 0.05 accepted as significant.
Ab-Bethyl Specifically Recognizes Human β2AR in HEK 293 Cells
Antibodies Used for IIF on HEK 293 Cells Expressing Human and Rat β2AR
Santa Cruz Biotechnology
C-terminal domain of human β2AR
N-terminal domain of human β2AR
N-terminal domain of human β2AR
Bethyl Laboratories, Inc.
Last 15 aa of C-terminal domain of human β2AR
Santa Cruz Biotechnology
C-terminal domain of mouse β2AR
78 aa of the C-terminus of the human β2AR
Ab-sc570 Specifically Recognizes Rat β2AR in HEK 293 Cells
Ab-13989 Specifically Recognizes Human and Rat β2AR in HEK 293 Cells
We conducted semi-quantitative studies to define a linear range for detecting human β2AR using Ab-13989 on four HEK 293 cell lines stably expressing different levels of the β2AR ranging from 280,000 to 2,900,000 receptors/cell. Samples were analyzed by both wide field and confocal epifluorescence microscopy. For wide field microscopy, optimal exposure times for image acquisition were determined by software. Low signal intensities required longer exposure times whereas high signal intensities required shorter exposure time. Therefore, an arbitrary intensity unit was defined as the inverse of the exposure time. These results are plotted in Figure 3E and show a linear relationship between receptor number and staining intensity (R = 0.97) from ~280,000 to ~1,400,000 receptors per cell. Above ~1,400,000 receptors per cell, the signal plateaued (probably from quenching due to the interfilter effect), so this value was not used to calculate the correlation coefficient. For confocal microscope analysis, images were taken under identical detection conditions and the integrated signal intensity measured on a cell by cell basis. Results were essentially identical to those using the wide field microscope with a correlation coefficient of 0.98 (Figure 3F).
Localization of the β2AR in Primary Cultures of Rat Airway Smooth Muscle and Rat Airway Epithelial Cells
The β2AR is an important target for medications used to treat respiratory and cardiovascular diseases. The development of tolerance to repetitive doses of β-agonist is a significant clinical problem. Therefore, studies on the molecular mechanism regulating β2AR activity after treatment and in different physiologic conditions are of importance in designing better therapies for treatment. Immunofluorescence and immunohistochemical methods are of value in studying trafficking and regulation of the β2AR because they can be used in the context of the whole tissue. In this study, we evaluated six β2AR antibodies developed against different portions of the β2AR. We identified one antibody that specifically recognized human β2AR, one antibody that specifically recognized rat β2AR, and one antibody capable of recognizing both rat and human β2AR. In HEK 293 cells, both rat and human β2AR were localized to the cell surface in untreated cells following transfection and moved into an intracellular compartment within a few hours of treatment with the β-agonist isoproterenol. Although these findings are in complete agreement with previous studies performed using tagged β2AR, results of an analysis of the localization of endogenous rat airway β2AR were not. We made the novel observation that almost half of the endogenous rat β2ARs are located in an intracellular compartment instead of being largely restricted to the plasma membrane. Specificity controls, and especially the fact that the pattern of staining was identical using two different antibodies raised against different potions of the receptor, support our conclusion.
It is possible that receptor localization in HEK 293 cells may be altered as a consequence of expressing receptors at a level 100 times higher than normal. Saturation of the mechanisms for constitutive internalization and intracellular retention of β2AR may account for the prominent cell surface expression consistently noted in HEK 293 cells. Alternatively, there could be cell-specific differences in internalization mechanisms that are independent of receptor number. In either case, the significant differences in receptor localization compromise the utility of using tagged receptors in HEK 293 cells to define receptor trafficking pathways relevant to the problem of β-agonist tolerance in airway smooth muscle or epithelial cells.
Our results demonstrating that almost half of the β2AR in cultures of primary airway cells are located inside the cells underscores the need for future studies assessing the location and trafficking of endogenous β2AR in airway smooth muscle and epithelium. The antibodies that we have characterized now provide the tools needed for such studies.
Support has been provided in part by the Arkansas Biosciences Institute, the major research component of the Tobacco Settlement Proceeds Act of 2000. The use of the facilities in the University of Arkansas for Medical Sciences Digital and Confocal Microscopy Laboratory supported by Grant Number 2 P20 RR 16460 (PI: L. Cornett, INBRE, Partnerships for Biomedical Research in Arkansas) and Grant Number 1 S10 RR 19395 (PI: R. Kurten, "Zeiss LSM 510 META Confocal Microscope System") from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), is acknowledged. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.
- Rasmussen H, Kelly G, Douglas JS: Interaction between Ca 2+ and cAMP messenger system in regulation of airway smooth muscle contraction. Am J Physiol Lung Cell Mol Physiol 1990, 258:L279-L288.Google Scholar
- Bai Y, Sanderson MJ: Airway smooth muscle relaxation results from a reduction in the frequency of Ca 2+ oscillations induced by a cAMP-mediated inhibition of the IP 3 receptor. Respiratory Research 2006, 7:34.View ArticlePubMedPubMed CentralGoogle Scholar
- Nuttle LC, Farley JM: Frequency modulation of acetylcholyne-induced oscillations in Ca ++ and Ca ++ activated Cl - current by cAMP in tracheal smooth muscle. J Pharmacol Exp Ther 1996, 277:753–60.PubMedGoogle Scholar
- Morrison KJ, Gao Y, Vanhoutte PM: Beta-adrenoreceptors and the epithelial layer in airways. Life Sci 1993, 52:2123–2130.View ArticlePubMedGoogle Scholar
- Peachell PT, MacGlashan DW Jr, Lichtenstein LM, Schleimer RP: Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988, 140:571–9.PubMedGoogle Scholar
- Pittet JF, Wiener-Kronish JP, McElroy MC, Folkesson HG, Matthay MA: Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. J Clin Invest 1994, 94:663–671.View ArticlePubMedPubMed CentralGoogle Scholar
- Chander A, Fisher A: Regulation of lung surfactant secretion. Am J Physiol 1990, 258:L241–53.PubMedGoogle Scholar
- Salathe M: Effects of β-agonists on airway epithelial cells. J Allergy Clin Immunol 2002,110(6 Suppl):275–281.View ArticleGoogle Scholar
- Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Krancke U, Caron MG, Lefkowitz RJ: cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci 1987,84(1):46–50.View ArticlePubMedPubMed CentralGoogle Scholar
- Lima JJ: New horizons in asthma: Importance of β 2 -adrenergic receptor polymorphisms. Jacksonville Medicine 1999, 488–490.Google Scholar
- Billington CK, Penn R: Signalling and regulation of G protein-coupled receptors in airway smooth muscle. Respiratory Research 2003, 4:2.View ArticlePubMedPubMed CentralGoogle Scholar
- Kurz JB, Perkins JP: Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells. Mol Pharmacol 1991,41(2):375–381.Google Scholar
- von Zastrow M, Kobilka BK: Ligand-regulated internalization and recycling of human β 2 -adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem 1992, 267:3530–3538.PubMedGoogle Scholar
- Schnackenberg BJ, Jones SM, Pate C, Shank B, Sessions L, Pittman LM, Cornett LE, Kurten RC: The β-agonist isoproterenol attenuates EGF-stimulated wound closure in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006, 290:L485-L491.View ArticlePubMedGoogle Scholar
- Cullen BR: Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 1987, 152:684–704.View ArticlePubMedGoogle Scholar
- Chen CA, Okayama H: Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 1988, 6:632–638.PubMedGoogle Scholar
- Jones SM, Hiller FC, Jacobi SE, Foreman SK, Pittman LM, Cornett LE: Enhanced beta2-adrenergic receptor (beta2AR) signaling by adeno-associated viral (AAV)-mediated gene transfer. BMC Pharmacol 2003, 3:15.View ArticlePubMedPubMed CentralGoogle Scholar
- Hanyaloglu AC, McCullagh E, von Zastrow M: Essential role of Hrs in a recycling mechanism mediating functional resensitization of cell signaling. EMBO Journal 2005, 24:2265–2283.View ArticlePubMedPubMed CentralGoogle Scholar
- Angres S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M: Detection of β 2 -adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). PNAS 2000, 97:3684–3689.Google Scholar
- Kallal L, Gagnon AW, Penn RB, Benovic JL: Visualization of agonist induced sequestration and down-regulation of a green fluorescent protein-tagged β 2 -adrenergic receptor. J Biol Chem 1998, 273:322–328.View ArticlePubMedGoogle Scholar
- Tsao PI, von Zastrow M: Type-specific sorting of G protein-coupled receptors after endocytosis. J Biol Chem 2000,275(15):11130–11140.View ArticlePubMedGoogle Scholar
- Moore RH, Tuffana A, Millman EE, Dai W, Hall HS, Dickey BF, Knoll BJ: Agonist-induced sorting of human β 2 -adrenergic receptors to lysosomes during downregulation. J Cell Sci 1999, 112:329–338.PubMedGoogle Scholar
- Liebler JM, Borok Z, Li X, Sandoval A, Kim K, Crandall ED: Alveolar epithelial type l cells express β 2 -adrenergic receptor and G-protein receptor kinase 2. J Histochem Cytochem 2004,52(6):759–767.View ArticlePubMedGoogle Scholar
- Skalli O, Schurch W, Seemayer T, Lagace R, Montandon D, Pittet B, Gabbiani G: Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989, 60:275–285.PubMedGoogle Scholar
- Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996, 84:345–57.View ArticlePubMedGoogle Scholar
- Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 2005, 6:622–634.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.